Novo Nordisk A/S (NVO)
NYSE: NVO · IEX Real-Time Price · USD
142.98
-2.44 (-1.68%)
At close: Jul 2, 2024, 4:00 PM
142.96
-0.02 (-0.01%)
After-hours: Jul 2, 2024, 7:58 PM EDT
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of $628.28 billion as of July 2, 2024. Its market cap has increased by 73.23% in one year.
Market Cap
628.28B
Enterprise Value
630.82B
1-Year Change
73.23%
Ranking
Category
Stock Price
$142.98
Market Cap Chart
Since December 31, 2002, Novo Nordisk's market cap has increased from $9.98B to $628.28B, an increase of 6,195.98%. That is a compound annual growth rate of 21.23%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 655.84B | 39.03% |
Dec 29, 2023 | 471.73B | 54.12% |
Dec 30, 2022 | 306.08B | 19.24% |
Dec 31, 2021 | 256.69B | 55.86% |
Dec 31, 2020 | 164.70B | 16.14% |
Dec 31, 2019 | 141.81B | 23.12% |
Dec 31, 2018 | 115.18B | -15.84% |
Dec 29, 2017 | 136.86B | 46.79% |
Dec 30, 2016 | 93.24B | -38.18% |
Dec 31, 2015 | 150.82B | 29.59% |
Dec 31, 2014 | 116.38B | 12.48% |
Dec 31, 2013 | 103.47B | 9.30% |
Dec 31, 2012 | 94.66B | 36.88% |
Dec 30, 2011 | 69.16B | -0.91% |
Dec 31, 2010 | 69.79B | 72.41% |
Dec 31, 2009 | 40.48B | 26.82% |
Dec 31, 2008 | 31.92B | -22.43% |
Dec 31, 2007 | 41.15B | 52.03% |
Dec 29, 2006 | 27.07B | 44.82% |
Dec 30, 2005 | 18.69B | 1.87% |
Dec 31, 2004 | 18.35B | 29.73% |
Dec 31, 2003 | 14.14B | 41.73% |
Dec 31, 2002 | 9.98B | - |
View and export this data all the way back to 2002.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 860.48B |
UnitedHealth Group | 468.72B |
Johnson & Johnson | 351.76B |
Merck & Co. | 313.56B |
AbbVie | 302.88B |
AstraZeneca | 241.81B |
Thermo Fisher | 211.09B |
Novartis AG | 208.29B |